Free Trial

VEON (VEON) Financials

VEON logo
$52.65 -0.48 (-0.90%)
Closing price 04:00 PM Eastern
Extended Trading
$52.00 -0.65 (-1.23%)
As of 06:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for VEON

Annual Income Statements for VEON

This table shows VEON's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders
415 -2,528 -162 674 -349 771 582 -10,042 -4,491 -655
Consolidated Net Income / (Loss)
487 -2,450 -9.00 801 -316 683 362 -10,013 -4,583 -553
Net Income / (Loss) Continuing Operations
487 380 733 120 94 582 -617 -10,013 -6,371 -815
Total Pre-Tax Income
704 559 802 464 373 1,132 -248 -9,541 -5,736 -595
Total Operating Income
1,110 929 1,163 1,023 823 1,865 554 -9,308 -5,701 524
Total Gross Profit
3,489 3,257 3,279 3,366 3,028 5,444 6,970 -3,484 -86 7,438
Total Revenue
4,004 3,698 3,755 3,850 3,482 8,162 9,086 -410 2,545 9,606
Operating Revenue
3,871 3,595 3,628 3,725 3,482 7,987 9,086 -410 2,397 9,503
Other Revenue
133 103 127 125 - 175 - - 148 103
Total Cost of Revenue
515 441 476 484 454 2,718 2,116 3,074 2,631 2,168
Operating Cost of Revenue
515 441 476 484 454 2,718 2,116 3,074 2,631 2,168
Total Operating Expenses
2,524 2,328 2,204 2,343 2,205 4,312 6,416 5,824 5,615 6,914
Selling, General & Admin Expense
1,799 1,646 1,533 1,526 1,403 2,736 3,697 3,748 3,668 4,563
Depreciation Expense
529 527 557 605 553 1,512 1,339 1,491 1,439 1,550
Amortization Expense
199 208 221 194 177 - 495 537 497 517
Other Operating Expenses / (Income)
-6.00 -47 0.00 -9.00 0.00 - -30 22 11 39
Impairment Charge
3.00 -6.00 -107 27 62 108 858 - - 245
Total Other Income / (Expense), net
-415 -370 -273 -559 -450 0.00 -802 -233 -35 -1,119
Interest Expense
495 531 583 591 569 333 816 - - 829
Interest & Investment Income
49 60 32 13 19 1.00 67 - - 52
Other Income / (Expense), net
31 101 278 19 100 332 -53 -233 -35 -342
Income Tax Expense
217 179 69 344 279 462 369 472 635 220
Net Income / (Loss) Discontinued Operations
0.00 -2,830 -742 681 -410 101 979 - 1,788 262
Net Income / (Loss) Attributable to Noncontrolling Interest
-72 -78 -153 -127 33 - -220 29 -92 102
Basic Earnings per Share
$0.23 ($1.44) $0.28 $0.38 ($0.20) - $0.33 - $1.33 ($0.37)
Weighted Average Basic Shares Outstanding
1.85B 1.76B 1.76B 1.76B 1.76B 1.76B 1.76B 1.76B - -
Diluted Earnings per Share
$0.23 ($1.44) ($0.09) $0.38 ($0.20) - $0.33 - $1.33 ($0.37)
Weighted Average Diluted Shares Outstanding
1.85B 1.76B 1.76B 1.76B 1.76B 1.76B 1.76B 1.76B - -
Weighted Average Basic & Diluted Shares Outstanding
1.85B 1.76B 1.76B 1.76B 1.76B 1.76B 1.76B 1.76B - -

Quarterly Income Statements for VEON

No quarterly income statements for VEON are available.


Annual Cash Flow Statements for VEON

This table details how cash moves in and out of VEON's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents
-179 -1,271 1,017 714 474 967 596 -1,274 -922 -2,040
Net Cash From Operating Activities
1,150 2,131 2,557 2,638 2,443 2,830 2,515 2,475 1,875 2,033
Net Cash From Continuing Operating Activities
1,150 1,160 933 961 844 2,830 2,515 2,462 1,082 1,104
Net Income / (Loss) Continuing Operations
704 559 802 464 373 0.00 -248 328 288 -595
Consolidated Net Income / (Loss)
704 559 802 464 373 - -248 328 288 -595
Depreciation Expense
731 729 671 826 792 - 2,692 2,094 2,128 1,550
Non-Cash Adjustments To Reconcile Net Income
-324 469 274 550 -321 2,659 -236 -227 706 -525
Changes in Operating Assets and Liabilities, net
40 -577 -814 -879 0.00 171 307 267 -2,040 157
Net Cash From Discontinued Operating Activities
0.00 951 1,624 1,677 1,599 - - - 683 929
Net Cash From Investing Activities
-679 -2,036 -1,642 -1,122 -1,797 -1,582 1,997 -3,016 -2,671 -2,634
Net Cash From Continuing Investing Activities
-778 -1,020 -1,043 -909 -816 -1,582 1,997 -3,036 -1,738 -2,494
Purchase of Property, Plant & Equipment
-627 -766 -634 -699 -550 -1,582 -1,948 -2,037 -1,651 -2,207
Acquisitions
-2.00 0.00 -16 0.00 0.00 - - - - -17
Purchase of Investments
-280 - -390 -207 -132 - -32 -1,165 -87 -
Sale of Property, Plant & Equipment
102 - - - - - - - - 18
Divestitures
36 0.00 - - -10 - - - 0.00 -
Sale and/or Maturity of Investments
92 - - - -8.00 - 3,958 166 - 74
Other Investing Activities, net
0.00 -53 -3.00 -3.00 -47 - 19 - - -362
Net Cash From Discontinued Investing Activities
0.00 -1,217 -599 -213 -1,050 - - - -649 -140
Net Cash From Financing Activities
-543 -1,339 116 -744 -103 -281 -3,916 -733 -126 -1,439
Net Cash From Continuing Financing Activities
-551 -919 456 -192 174 -281 -3,916 -733 -106 -734
Repayment of Debt
-1,483 -1,098 -1,619 -1,977 -4,148 -2,891 -4,122 -5,948 -1,816 -4,840
Payment of Dividends
-15 -15 -12 -17 -298 - -601 -719 -167 -249
Issuance of Debt
955 - 2,087 2,081 4,621 2,610 807 6,193 1,882 2,052
Net Cash From Discontinued Financing Activities
0.00 -226 -340 -552 -277 - - - -20 -707

Quarterly Cash Flow Statements for VEON

No quarterly cash flow statements for VEON are available.


Annual Balance Sheets for VEON

This table presents VEON's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Total Assets
8,036 8,218 15,083 15,921 14,551 16,059 14,102 19,484 21,193
Total Current Assets
2,828 3,158 3,981 3,553 2,850 2,499 3,110 3,164 4,550
Cash & Equivalents
1,689 1,902 3,107 2,252 1,669 1,250 1,808 1,314 2,942
Short-Term Investments
357 433 120 86 90 82 88 1,130 190
Accounts Receivable
463 542 456 690 572 628 577 - 685
Inventories, net
15 23 18 111 111 169 141 72 125
Current Deferred & Refundable Income Taxes
63 58 72 70 73 16 112 - 169
Other Current Assets
241 200 208 344 335 354 367 648 439
Plant, Property, & Equipment, net
0.00 0.00 0.00 6,717 6,879 7,340 4,932 6,237 6,719
Total Noncurrent Assets
2,192 2,162 8,254 5,651 670 6,220 6,077 5,239 9,899
Intangible Assets
1,510 1,619 1,960 3,244 - 5,688 5,670 - 2,257
Noncurrent Deferred & Refundable Income Taxes
368 312 274 228 186 134 197 336 343
Other Noncurrent Operating Assets
242 231 228 315 484 398 193 263 424
Other Noncurrent Nonoperating Assets
72 0.00 5,792 1,864 0.00 - 17 22 0.00
Total Liabilities & Shareholders' Equity
8,036 8,218 15,083 15,921 14,551 16,059 14,102 19,484 21,193
Total Liabilities
6,751 7,147 14,316 14,416 13,538 13,839 11,323 15,579 15,150
Total Current Liabilities
3,626 3,584 4,645 4,383 4,410 5,768 4,413 4,635 6,557
Short-Term Debt
1,666 1,692 2,844 1,242 1,255 2,585 1,289 1,268 3,046
Accounts Payable
1,276 1,200 1,087 2,031 1,946 1,847 1,624 1,544 1,744
Current Deferred & Payable Income Tax Liabilities
179 154 180 228 175 102 196 - 57
Other Current Liabilities
432 457 475 773 883 1,012 1,066 1,401 1,236
Other Current Nonoperating Liabilities
73 81 59 109 151 222 234 422 474
Total Noncurrent Liabilities
3,125 3,563 5,439 9,642 9,128 8,071 6,910 10,944 8,593
Noncurrent Deferred & Payable Income Tax Liabilities
27 26 36 115 127 141 180 376 331
Other Noncurrent Operating Liabilities
3,098 3,537 5,403 9,527 9,001 7,930 6,730 10,568 8,262
Other Noncurrent Nonoperating Liabilities
28 0.00 4,232 391 0.00 - 4.00 15 0.00
Total Equity & Noncontrolling Interests
1,257 1,071 767 1,505 1,013 2,220 2,779 3,890 6,043
Total Preferred & Common Equity
1,099 858 569 586 163 1,226 3,670 4,331 5,960
Total Common Equity
1,099 858 569 586 163 1,226 3,670 4,331 5,960
Other Equity Adjustments
1,099 858 569 586 163 1,226 3,670 4,331 5,960
Noncontrolling Interest
158 213 198 919 850 994 -891 -441 83

Quarterly Balance Sheets for VEON

No quarterly balance sheets for VEON are available.


Annual Metrics And Ratios for VEON

This table displays calculated financial ratios and metrics derived from VEON's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
8.27% -1.52% -2.47% 10.57% -57.34% -10.17% 2,316.10% -116.11% -73.51% 0.00%
EBITDA Growth
11.56% -16.71% 13.06% 8.92% -53.76% 16.16% 142.88% -106.40% -260.43% 0.00%
EBIT Growth
20.23% -28.52% 38.29% 12.89% -57.99% 338.52% 105.25% -66.34% -3,251.65% 0.00%
NOPAT Growth
21.59% -40.59% 301.76% 27.56% -81.21% 184.64% 105.95% -63.27% -1,187.98% 0.00%
Net Income Growth
119.88% -27,122.22% -101.12% 353.48% -146.27% 88.67% 103.62% -118.48% -728.75% 0.00%
EPS Growth
115.97% -1,500.00% -101.12% 353.48% 0.00% 0.00% 0.00% 0.00% 459.46% 0.00%
Operating Cash Flow Growth
-46.03% -16.66% -3.07% 7.98% -13.67% 12.52% 1.62% 32.00% -7.77% 0.00%
Free Cash Flow Firm Growth
151.76% -123.19% 279.23% -130.73% 3,831.58% 94.67% -548.57% 93.02% 0.00% 0.00%
Invested Capital Growth
11.68% 39.75% -315.18% 72.65% -194.51% 54.41% 239.53% -140.57% 0.00% 0.00%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - -
Gross Margin
87.14% 88.07% 87.32% 87.43% 86.96% 66.70% 76.71% 0.00% -3.38% 77.43%
EBITDA Margin
46.75% 47.57% 56.25% 48.52% 49.25% 45.44% 35.14% 0.00% -141.77% 23.41%
Operating Margin
27.72% 25.12% 30.97% 26.57% 23.64% 22.85% 6.10% 0.00% -224.01% 5.45%
EBIT Margin
28.50% 27.85% 38.38% 27.06% 26.51% 26.92% 5.51% 0.00% -225.38% 1.89%
Profit (Net Income) Margin
12.16% -66.25% -0.24% 20.81% -9.08% 8.37% 3.98% 0.00% -180.08% -5.76%
Tax Burden Percent
69.18% -438.28% -1.12% 172.63% -84.72% 60.34% -145.97% 104.95% 79.90% 92.94%
Interest Burden Percent
61.70% 54.27% 55.66% 44.53% 40.41% 51.52% -49.50% 100.00% 100.00% -326.92%
Effective Tax Rate
30.82% 32.02% 8.60% 74.14% 74.80% 40.81% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 204.34% 36.26% 114.40% 0.00% -188.82% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 238.89% -41.03% 115.26% 0.00% -123.59% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% -223.89% -8.94% -103.54% 0.00% 37.14% 0.00%
Return on Equity (ROE)
41.84% -266.59% -0.79% 63.62% -19.55% 27.33% 10.86% -201.61% -151.68% 0.00%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% -6.51% -155.46% 0.00% -388.82% 0.00%
Operating Return on Assets (OROA)
14.04% 8.84% 9.30% 6.84% 6.03% 14.57% 2.98% 0.00% -27.07% 0.00%
Return on Assets (ROA)
5.99% -21.03% -0.06% 5.26% -2.06% 4.53% 2.16% 0.00% -21.63% 0.00%
Return on Common Equity (ROCE)
35.17% -206.98% -0.40% 18.92% -8.40% 26.76% 13.02% -208.88% -149.60% 0.00%
Return on Equity Simple (ROE_SIMPLE)
44.31% -285.55% -1.58% 136.69% -193.87% 55.71% 9.86% -231.19% -76.90% 0.00%
Net Operating Profit after Tax (NOPAT)
768 632 1,063 265 207 1,104 388 -6,516 -3,991 367
NOPAT Margin
19.18% 17.08% 28.31% 6.87% 5.96% 13.52% 4.27% 0.00% -156.81% 3.82%
Net Nonoperating Expense Percent (NNEP)
-8.23% -75.23% -29.81% 15.40% -34.55% 77.29% -0.86% -94.26% -65.23% 0.00%
Return On Investment Capital (ROIC_SIMPLE)
26.27% - - - - - - - - -
Cost of Revenue to Revenue
12.86% 11.93% 12.68% 12.57% 13.04% 33.30% 23.29% 0.00% 103.38% 22.57%
SG&A Expenses to Revenue
44.93% 44.51% 40.83% 39.64% 40.29% 33.52% 40.69% 0.00% 144.13% 47.50%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
63.04% 62.95% 58.70% 60.86% 63.33% 52.83% 70.61% 0.00% 220.63% 71.98%
Earnings before Interest and Taxes (EBIT)
1,141 1,030 1,441 1,042 923 2,197 501 -9,541 -5,736 182
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,872 1,759 2,112 1,868 1,715 3,709 3,193 -7,447 -3,608 2,249
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
64.10 40.34 1.51 5.13 16.27 3.38 0.93 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 16.27 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
17.59 9.36 0.23 0.78 0.76 0.51 0.38 0.00 0.00 0.00
Price to Earnings (P/E)
169.75 0.00 0.00 4.46 0.00 5.38 5.85 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 29.80% 12.71% 14.95% 11.83% 1.31% 1.55%
Earnings Yield
0.59% 0.00% 0.00% 22.44% 0.00% 18.59% 17.08% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 1.73 0.80 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
17.54 9.24 0.18 0.73 0.86 0.78 0.21 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
37.51 19.43 0.32 1.51 1.75 1.72 0.60 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
61.55 33.18 0.47 2.71 3.25 2.91 3.81 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
91.45 54.12 0.64 10.69 14.46 5.79 4.92 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
61.06 16.04 0.26 1.07 1.23 2.26 0.76 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
143.65 0.00 0.17 0.00 0.41 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
1.33 1.58 3.71 0.83 1.24 1.16 0.46 0.33 0.50 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-2.93 -4.46 -3.17 -2.77 -0.94 0.22 -0.90 -0.75 -0.30 0.00
Leverage Ratio
6.98 12.68 13.65 12.10 9.47 6.03 5.04 4.10 3.51 0.00
Compound Leverage Factor
4.31 6.88 7.59 5.39 3.83 3.11 -2.49 4.10 3.51 0.00
Debt to Total Capital
57.00% 61.24% 78.76% 45.21% 55.34% 53.80% 31.69% 24.58% 33.51% 0.00%
Short-Term Debt to Total Capital
57.00% 61.24% 78.76% 45.21% 55.34% 53.80% 31.69% 24.58% 33.51% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
5.41% 7.71% 5.48% 33.45% 37.48% 20.69% -21.90% -8.55% 0.91% 0.00%
Common Equity to Total Capital
37.60% 31.05% 15.76% 21.33% 7.19% 25.52% 90.22% 83.97% 65.57% 0.00%
Debt to EBITDA
0.89 0.96 1.35 0.66 0.73 0.70 0.40 -0.17 -0.84 0.00
Net Debt to EBITDA
-0.20 -0.37 -0.18 -0.59 -0.29 0.34 -0.19 0.16 0.63 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
2.17 2.68 2.68 4.69 6.05 2.34 3.32 -0.19 -0.76 0.00
Net Debt to NOPAT
-0.49 -1.02 -0.36 -4.14 -2.43 1.14 -1.57 0.18 0.57 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
7.11 3.71 0.55 0.52 0.44 0.90 0.83 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio
15.94% 22.36% 49.16% 70.25% 57.04% 2.06% -19.97% -3.60% 1.37% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
0.78 0.88 0.86 0.81 0.65 0.43 0.70 0.68 0.69 0.00
Quick Ratio
0.69 0.80 0.79 0.69 0.53 0.34 0.56 0.53 0.58 0.00
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
489 -944 4,073 -2,272 7,394 -198 -3,720 -574 -8,218 0.00
Operating Cash Flow to CapEx
219.05% 278.20% 403.31% 377.40% 444.18% 178.89% 129.11% 121.50% 113.57% 92.87%
Free Cash Flow to Firm to Interest Expense
0.99 -1.78 6.99 -3.85 13.00 -0.60 -4.56 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
2.32 4.01 4.39 4.46 4.29 8.50 3.08 0.00 0.00 2.45
Operating Cash Flow Less CapEx to Interest Expense
1.26 2.57 3.30 3.28 3.33 3.75 0.69 0.00 0.00 -0.19
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.49 0.32 0.24 0.25 0.23 0.54 0.54 0.00 0.12 0.00
Accounts Receivable Turnover
7.97 7.41 6.55 6.10 5.80 13.55 0.00 0.00 3.72 0.00
Inventory Turnover
27.11 21.51 7.38 4.36 3.24 17.54 19.87 31.21 21.05 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.57 0.49 1.33 1.63 0.00 0.38 0.00
Accounts Payable Turnover
0.42 0.39 0.31 0.24 0.24 1.57 1.34 1.87 1.51 0.00
Days Sales Outstanding (DSO)
45.81 49.25 55.70 59.82 62.89 26.94 0.00 0.00 98.24 0.00
Days Inventory Outstanding (DIO)
13.47 16.97 49.46 83.71 112.56 20.81 18.37 11.70 17.34 0.00
Days Payable Outstanding (DPO)
877.42 946.43 1,195.45 1,499.59 1,524.72 233.06 273.23 195.20 241.95 0.00
Cash Conversion Cycle (CCC)
-818.14 -880.21 -1,090.29 -1,356.06 -1,349.27 -185.30 -254.86 0.00 -126.36 0.00
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
-2,110 -2,389 -3,965 -955 -3,492 3,695 2,393 -1,715 4,227 0.00
Invested Capital Turnover
-1.78 -1.16 -1.53 -1.73 34.31 2.68 26.80 0.00 1.20 0.00
Increase / (Decrease) in Invested Capital
279 1,576 -3,010 2,537 -7,187 1,302 4,108 -5,942 4,227 0.00
Enterprise Value (EV)
70,223 34,178 676 2,827 2,999 6,394 1,910 0.00 0.00 0.00
Market Capitalization
70,445 34,608 861 3,004 2,653 4,147 3,408 0.00 0.00 0.00
Book Value per Share
$0.63 $0.49 $0.32 $0.33 $0.09 $0.70 $2.09 $2.47 $0.00 $0.00
Tangible Book Value per Share
($0.23) ($0.43) ($0.79) ($1.51) $0.09 ($2.54) ($1.14) ($0.16) $0.00 $0.00
Total Capital
2,923 2,763 3,611 2,747 2,268 4,805 4,068 5,158 9,089 0.00
Total Debt
1,666 1,692 2,844 1,242 1,255 2,585 1,289 1,268 3,046 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-380 -643 -383 -1,096 -504 1,253 -607 -1,176 -2,265 0.00
Capital Expenditures (CapEx)
525 766 634 699 550 1,582 1,948 2,037 1,651 2,189
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-1,178 -1,069 -1,047 -1,926 -2,064 -2,016 -1,910 -2,647 -2,093 0.00
Debt-free Net Working Capital (DFNWC)
868 1,266 2,180 412 -305 -684 -14 -203 1,039 0.00
Net Working Capital (NWC)
-798 -426 -664 -830 -1,560 -3,269 -1,303 -1,471 -2,007 0.00
Net Nonoperating Expense (NNE)
281 3,082 1,072 -536 523 421 26 3,497 592 920
Net Nonoperating Obligations (NNO)
-3,367 -3,460 -4,732 -2,460 -4,505 1,475 -386 -5,605 -1,816 0.00
Total Depreciation and Amortization (D&A)
731 729 671 826 792 1,512 2,692 2,094 2,128 2,067
Debt-free, Cash-free Net Working Capital to Revenue
-29.42% -28.91% -27.88% -50.03% -59.28% -24.70% -21.02% 0.00% -82.24% 0.00%
Debt-free Net Working Capital to Revenue
21.68% 34.23% 58.06% 10.70% -8.76% -8.38% -0.15% 0.00% 40.83% 0.00%
Net Working Capital to Revenue
-19.93% -11.52% -17.68% -21.56% -44.80% -40.05% -14.34% 0.00% -78.86% 0.00%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.23 ($1.44) ($0.09) $0.00 ($5.00) $9.00 $0.00 ($7.00) $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
1.85B 1.76B 1.76B 0.00 70.27M 70.27M 70.27M 70.27M 0.00 0.00
Adjusted Diluted Earnings per Share
$0.23 ($1.44) ($0.09) $0.00 ($5.00) $9.00 $0.00 ($7.00) $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
1.85B 1.76B 1.76B 0.00 70.27M 70.27M 70.27M 70.27M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 ($5.00) $9.00 $0.00 ($7.00) $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.85B 1.76B 1.76B 0.00 70.27M 70.27M 70.27M 70.27M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
770 627 965 735 627 1,142 1,028 -6,497 -3,991 538
Normalized NOPAT Margin
19.23% 16.97% 25.70% 19.09% 17.99% 13.99% 11.32% 0.00% -156.81% 5.60%
Pre Tax Income Margin
17.58% 15.12% 21.36% 12.05% 10.71% 13.87% -2.73% 0.00% -225.38% -6.19%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
2.31 1.94 2.47 1.76 1.62 6.60 0.61 0.00 0.00 0.22
NOPAT to Interest Expense
1.55 1.19 1.82 0.45 0.36 3.31 0.48 0.00 0.00 0.44
EBIT Less CapEx to Interest Expense
1.24 0.50 1.38 0.58 0.66 1.85 -1.77 0.00 0.00 -2.42
NOPAT Less CapEx to Interest Expense
0.49 -0.25 0.74 -0.74 -0.60 -1.44 -1.91 0.00 0.00 -2.20
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
3.08% -0.61% -133.33% 2.12% -94.30% 0.00% 166.02% -7.18% -3.64% -45.03%
Augmented Payout Ratio
3.08% -0.61% -133.33% 2.12% -94.30% 0.00% 166.02% -7.18% -3.64% -45.03%

Quarterly Metrics And Ratios for VEON

No quarterly metrics and ratios for VEON are available.


Frequently Asked Questions About VEON's Financials

When does VEON's financial year end?

According to the most recent income statement we have on file, VEON's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has VEON's net income changed over the last 9 years?

VEON's net income appears to be on a downward trend, with a most recent value of $487 million in 2024, falling from -$553 million in 2015. The previous period was -$2.45 billion in 2023. See where experts think VEON is headed by visiting VEON's forecast page.

What is VEON's operating income?
VEON's total operating income in 2024 was $1.11 billion, based on the following breakdown:
  • Total Gross Profit: $3.49 billion
  • Total Operating Expenses: $2.52 billion
How has VEON revenue changed over the last 9 years?

Over the last 9 years, VEON's total revenue changed from $9.61 billion in 2015 to $4.00 billion in 2024, a change of -58.3%.

How much debt does VEON have?

VEON's total liabilities were at $6.75 billion at the end of 2024, a 5.5% decrease from 2023, and a 55.4% decrease since 2016.

How much cash does VEON have?

In the past 8 years, VEON's cash and equivalents has ranged from $1.25 billion in 2019 to $3.11 billion in 2022, and is currently $1.69 billion as of their latest financial filing in 2024.

How has VEON's book value per share changed over the last 9 years?

Over the last 9 years, VEON's book value per share changed from 0.00 in 2015 to 0.63 in 2024, a change of 62.6%.



This page (NASDAQ:VEON) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners